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ABSTRACT 
Objectives: These studies were undertaken to assess the mechanism of Curcuma xanthorrhiza and Morinda citrifolia granules combination as anti-
hyperlipidemic agent by immunohistochemical analysis in rats model. 
Methods: The rats were given HFD by oral gavage and PTU in drink water for 10 days to induce hyperlipidemia. Then they were randomized and 
divided into six groups, negative control, simvastatin control, gemfibrozil control, and three treatment groups. The treatment group rats was treated 
with extract granules combination at 137; 411; 686 mg/kg body weight that administered orally for 28 days. By immunohistochemistry 
preparation, jejunum was scored for NPC1L1 expression, so do adipose tissue was score for LPL expression. 
Results: Curcuma xanthorrhiza and Morinda citrifolia extract granules combination significantly (p<0.05) increased LPL expression at all dose (137; 
411; 686 mg/kgBW). Curcuma xanthorrhiza and Morinda citrifolia extract granules combination also significantly (p<0.05) decreased NPC1L1 
expression at dose 411 and 686 mg/kgBW, but not significant (p>0.05) at dose 137 mg/kgBW. 
Conclusions: Curcuma xanthorrhiza and Morinda citrifolia extract granules combination can increase lipoprotein lipase expression, a rate limiting 
enzyme of plasma triglyceride removal and decrease NPC1L1 expression, an intestinal cholesterol absorption transporter. 
Keywords: Morinda citrifolia L, Curcuma xanthorrhiza Roxb, Antihyperlipidemia, LPL, NPC1L1, Immunohistochemistry. 
 
INTRODUCTION 
Curcuma xanthorrhiza is a plant belonging to Ziberaceae family. 
Curcuma xanthorrhiza is a low growing plant with a root (rhizome) 
which is similar to ginger, with an aromatic, pungent odor and bitter 
taste. Curcuma xanthorrhiza or commonly known as temulawak in 
Indonesia is one of the traditional medicine used for the treatment of 
many disease such as hepatitis, liver complaints, diabetes, 
rheumatism, anticancer, hypertension and heart disorders. People 
use it also for reducing cholesterol [1]. Rhizome of Curcuma 
xanthorrhiza contains two characteristic constituent, i. e. 
Curcuminoid (curcumin and desmethoxycurcumin) and 
xanthorrhizol. Experimental studies showed that curcumin can 
lower total cholesterol in a variety of animals, such as a decrease in 
serum cholesterol in rodents, inhibits LDL oxidation in rabbits that 
had atherosclerosis, and a decrease in the ratio of LDL / HDL in 
hamsters. Not only in experimental animals, several studies also 
have shown hypolipidemic effect of curcumin on human [2]. 
Morinda citrifolia Linn (Fam. Rubiaceae) commonly known as 
mengkudu in Indonesia can used in folk medicine from the different 
part of its including fruit, leaves, root, stem, and bark. Experimental 
studies showed that these are effective against minimizing the 
symptomps of life style-related disease such as atherosclerosis, 
hypertension, and other vascular disorders, stroke, diabetes, and 
cancer [3]. Morinda citrifolia fruit juice has been widely consumed in 
Indonesia as a lipid-lowering. About 169 compounds were identified 
in Morinda citrifolia and the main micronutrient are phenolic 
compounds, organic acids, and alkaloids [4]. Scopoletin is a major 
compound and commonly used as a marker for Morinda citrifolia [5]. 
Scopoletin is reported to have a variety of theraupetic activity 
especially for hyperlipidemia [6]. 
Because of these anti-hyperlipidemia activities of both Curcuma 
xanthorrhiza and Morinda citrifolia, gave an idea for using them as a 
combination for treatment anti hyperlipidemic agent. We used 
immunohistochemical analysis to examine mechanism of Curcuma 
xanthorrhiza and Morinda citrifolia granules combination as anti-
hyperlipidemic agent. 
MATERIALS AND METHODS 
Materials 
Curcuma xanthorrhiza Roxb. and Morinda citrifolia L. ethanolic 
extract granules combination were formulated at Faculty of 
Pharmacy Airlangga University. Granules combination was 
containing C. xanthorrhiza and M. citrifolia extracts (1:2). 
HFD were prepared from 2% Cholesterol (Sigma Aldrich), 15% egg 
yolks, 58% animal fat, 10% nabati oil, 15% sucrose. The following 
drugs were obtained from the source specified: Propylthiouracil 
(Dexa Medica, Tangerang, Indonesia); Simvastatin (Hexpharm Jaya 
Laboratories, Jakarta, Indonesia); Gemfibrozil (PT Indofarma, 
Cikarang, Indonesia). 
Animals and study design 
Thirty six healthy Albino rats (100-250 g) were obtained from the 
animal house of Faculty of Pharmacy, Airlangga University, 
Surabaya. The animals were housed in a temperature-controlled 
environment (23-25°C), kept under laboratory conditions in plastic 
cage (47×34×18 cm3) with sawdust (renewed after every 48 h) and 
free acces to food and water. The experimental protocols was 
approved by the Animal Care and Use Committee at Faculty of 
Veterinary Medicine, Airlangga University. 
The rats were given 12,5 g/kg HFD by oral gavage and 0,02% of PTU 
in drink water for 10 days to induce hyperlipidemia. Then, they were 
randomized and divided into six groups and continually 
administered with normal chow (negative control group); oral 
gavage of 0,9 mg/kg of simvastatin (simvastatin control group); oral 
gavage of 27 mg/kg of gemfibrozil (gemfibrozil control group); oral 
gavage of C. xanthorrhiza and M. citrifolia granules combination (137 
mg/kg) (Dose I group); oral gavage of C. xanthorrhiza and M. 
citrifolia granules combination (411 mg/kg) (Dose II group); or oral 
gavage of C. xanthorrhiza and M. citrifolia granules combination (686 
mg/kg) (Dose III group) daily for 28 days, respectively. At the end of 
dietary control and treatments, rats were starved for 18 hrs and 
sacrified by overdose of anesthesia. Jejunum and adipose tissues 
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were collected for further immunohistochemistry analysis. Samples 
were then fixed in neutral buffered 10% formalin, processed for 
immuno histochemical analysis using LPL and NPC1L1 immuno 
labeling. 
Immuno histochemistry 
The immune staining for LPL and NPC1L1 was performed using 
Rabbit Anti-LPL Protein/Lipoprotein lipase Polyclonal Antibody bs-
2336R (Bioss Antibodies), and goat Anti-NPC1L1 Protein/NPC1L1 
Polyclonal Antibody sc-49063 (Santa Cruz Biotechnology). 
Positive cells expressing LPL were identified by a brown staining on 
the surface of adipocyte cell membrane, while NPC1L1 was 
demonstrated on brush border membran from jejunum.  
To ensure the objectivity of the analysis, the evaluation was carried 
out by 2 independent observers. Five sections were randomly 
chosen for each animal. Each tissue sections were stained and 
examined under a light microscope. 
The level of LPL and NPC1L1 expression was evaluated according to 
the scoring system of IRS classification [7]. Staining of LPL and 
NPC1L1 was assessed both as the fraction of positive cells (0% = 0; 
<10% = 1; 10 to 50% = 2; 51 to 80% = 3; >80% = 4) and the staining 
intensity (negative = 0; weak = 1; moderate = 2; strong = 3). 
Immunoreactive score (IRS) with points 0-12 obtained from 
multiplication of fraction of positive cells and staining intensity 
classified into 4-point-IRS-classification (0 to 1 = 0; 2 to 3 = 1; 4 to 8 
= 2; and 9 to 12 = 3). 
Statistical analysis 
Values were expressed as mean ± SD. The difference among groups 
was analyzed by Kruskall Wallis test using the SPSS 16.0 software. 
The accepted level of significance was p<0.05. 
RESULTS AND DISCUSSION 
Immunohistochemical lipoprotein lipase expression in adipose 
tissues 
LPL is the rate-limiting enzyme for the import of triglyceride-
derived fatty acids by muscle, for utilization, and adipose tissue (AT), 
for storage [8]. LPL is important in the removal of plasma 
triglyceride and found in many adipose and muscle tissue [9]. It is an 
enzyme that hydrolyzing triglycerides into free fatty acids and 
monoacylglycerol molecules [10]. 
 
 
Fig. 1: Immunohistochemical images (x400) of LPL staining in rats adipose tissues. (A) Negative control group rat; (B) gemfibrozil control group 
rat; (C) C. xanthorrhiza and M. citrifolia extract granules combination (137 mg/kg) group rat; (D) C. xanthorrhiza and M. citrifolia extract granules 
combination (411 mg/kg) group rat; and (E) C. xanthorrhiza and M. citrifolia extract granules combination (686 mg/kg) group rat 
 
The LPL immune staining results showed positive immunoreaction 
(brown colour) on the surface of adipocyte cell membrane (figure 1). 
Administration of C. xanthorrhiza and M. citrifolia granules 
combination or gemfibrozil gave increasing of LPL expression 
(figure 2). There was a statistically significant difference (P<0.05) 
present between negative control group (1,2 ± 0,4) and the other 
four groups regarding the LPL expression, but a statistically no 
significant difference (P>0.05) was observed between group 1 (2.5 ± 
0.5) and 2 (2.5 ± 0.8), 1 and 3 (2.7 ± 0.8) or between group 2 and 3. 
Gemfibrozil, an antihyperlipidemic agent from fibrate class, is widely 
preferred being the first line for reducing triglyceride in 
hyperlipidemic patients [11]. Lipoprotein lipase activity increased 
significantly by 25% after gemfibrozil [12] and it was associated 
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with its triglyceride decreasing activity [13]. From the results above 
showed that administration of C. xanthorrhiza and M. citrifolia 
extract granules combination increased LPL expression. Compounds 
that may be responsible for increasing LPL expression after 
administration of C. xanthorrhiza and M. citrifolia extract granules 
combination is scopoletin in M. citrifolia. A research conducted by 
[14] showed that scopoletin increased LPL activity in culture 
medium 3T3-L1 adipocytes with transcriptional control mechanism 
by increasing LPL mRNA level. Scopoletin also partially reversed 
tumor necrosis factor-α-induced suppression of LPL activity. These 
results suggest the possible action of scopoletin in M. citrifolia as a 
facilitator of plasma trigliceryde cleareance. 
 
 
Fig. 2: Scores mean of LPL expression in rats adipose tissues. Data 
are expressed as mean ± SD of each group (n = 6 per group). 
 
Immunohistochemical NPC1L1 expression in jejunum 
Niemann-pick C1 Like 1 (NPC1L1) protein has been identified as a 
spesific transporter for cholesterol uptake at the surface of plasma 
membrane [15]. Ezetimibe binds to NPC1L1, inhibits cholesterol 
absorption and is a clinically used as cholesterol plasma lowering [16]. 
The NPC1L1 immune staining results showed positive 
immunoreaction (brown colour) on brush border membran from 
jejunum (figure 3). Means of NPC1L1 scores showed decreasing of 
NPC1L1 expression with administration of C. xanthorrhiza and M. 
citrifolia granules combination or gemfibrozil (figure 4). There was a 
statistically significant difference regarding the LPL expression 
(P<0.05) present between negative control group (2.8 ± 0.4) and 
group 2 (2.0 ± 0.6) or group 3 (1.3 ± 0.8), group 1 (2.5 ± 0.8) and 3, 
but a statistically no significant difference (P>0.05) was observed 
between negative control group and group 1 or simvastatin control 
group (2.5 ± 0.8), group 1 and 2, group 2 and 3. 
The use of ezetimibe and simvastatin combination showed higher 
NPC1L1 expression decreased than single ezetimibe administration, 
it is possible that NPC1L1 expression also influenced by other 
proteins involved in lipid metabolism. But still there was no report 
on the effect of single simvastatin administration on the NPC1L1 
expression (Telford et al., 2007). From the results above showed 
that administration of C. xanthorrhiza and M. citrifolia extract 
granules combination decreased NPC1L1 expression. Compounds 
that may be responsible for decreasing of NPC1L1 expression after 
administration of C. xanthorrhiza and M. citrifolia extract granules 
combination is curcumin in C. xanthorrhiza. A research conducted by 
Feng et al (2010) [15] showed curcumin pretreated cells inhibited 
cholesterol uptake mediated by NPC1L1 in Caco-2 cells in vitro. 
Curcumin-induced inhibition of cholesterol uptake was associated 
with significant decrease in the levels of NPC1L1 protein and NPC1L1 
mRNA, as analyzed by Western blot and qPCR, respectively. Kumar et 
al (2011) [17] investigate the effect of curcumin on NPC1L1 function, 
expression, and promoter activity in intestinal Caco-2 monolayers. 
Curcumin treatment of Caco-2 monolayers also significantly decreased 
NPC1L1 mRNA and protein expression. Similarly, the promoter 
activity of the NPC1L1 gene was inhibited significantly (55%) by 50 
μM curcumin. These results suggest the possible action of curcumin in 
C. xanthorrhiza as a facilitator of plasma cholesterol cleareance. 
 
 
Fig. 3:Immunohistochemical images (x400) of NPC1L1 staining in rats jejunum. (A) Negative control group rat; (B) simvastatin control group 
rat; (C) C. xanthorrhiza and M. citrifolia extract granules combination (137 mg/kg) group rat; (D) C. xanthorrhiza and M. citrifolia extract 
granules combination (411 mg/kg) group rat; and (E) C. xanthorrhiza and M. citrifolia extract granules combination (686 mg/kg) group rat 
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Fig. 4: Scores mean of NPC1L1 expression in rats jejunum. Data are expressed as mean ± SD of each group (n = 6 per group). 
 
CONCLUSION 
Curcuma xanthorrhiza and Morinda citrifolia extract granules 
combination can increase lipoprotein lipase expression, a rate 
limiting enzyme of plasma triglyceride removal, on adipocyte cell 
and decrease NPC1L1 expression, an intestinal cholesterol 
absorption transporter, on brush border membran.  
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